Description

Zipelor (benzidamine hydrochloride) solution for the oral cavity 1.5 mg/ml. 100 ml. vial №1

Ingredients

Active ingredient: Benzidamine hydrochloride. Other ingredients: [list other ingredients here].

Dosage

Recommended dosage: For adults and children over 12 years old, rinse with 15 ml of solution for 30 seconds, 2-3 times daily after meals. Do not swallow.

Indications

Zipelor solution is indicated for the relief of pain and inflammation in the oral cavity, including sore throat, mouth ulcers, and post-dental procedures.

Contraindications

Do not use Zipelor solution if you are allergic to benzidamine hydrochloride or any other ingredients in the product. Consult a healthcare professional before use if pregnant, breastfeeding, or under medical supervision.

Directions

Shake the vial before use. Rinse the mouth with the solution for the recommended time, then spit out. Avoid eating or drinking for at least 30 minutes after use.

Scientific Evidence

Benzidamine hydrochloride, the active ingredient in Zipelor solution, has been extensively studied for its anti-inflammatory and analgesic properties. Research has shown that benzidamine can effectively reduce pain and inflammation in various oral conditions, providing relief to patients.

Additional Information

It is important to follow the recommended dosage and usage instructions provided with Zipelor solution to maximize its effectiveness and minimize any potential side effects. If symptoms persist or worsen after using the product, discontinue use and consult a healthcare professional.

Pharmacological Effects: Benzidamine hydrochloride exerts its pharmacological action by inhibiting the production of inflammatory mediators such as prostaglandins and leukotrienes, thereby reducing pain and inflammation in the oral cavity.

Clinical Trials: Clinical trials have demonstrated the efficacy of benzidamine hydrochloride in providing symptomatic relief in various oral conditions, with a favorable safety profile. Patients using Zipelor solution reported significant improvements in pain and discomfort compared to placebo groups.